GGHC
TBRA

Gilder Gagnon Howe & Co’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-252,219
Closed -$15.4M – 325
2014
Q2 		$15.4M Buy
252,219
+251,053
+21,531% +$15.3M 0.2% 102
2014
Q1 		$131K Buy
+1,166
New +$81.8K ﹤0.01% 254

Other funds holding TBRA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $167M AUM 33.45% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Gilder Gagnon Howe & Co's TBRA Position: Q3 2014 in Review

Gilder Gagnon Howe & Co sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2014, closing a stake of 252,219 shares — an estimated $15.4M sold.

Gilder Gagnon Howe & Co first reported a position in TBRA in Q1 2014 and held it in 2 quarters. The position peaked at $15.4M in Q2 2014. 47 funds tracked by Wall St. Rank hold TBRA as of Q3 2014.

  • Gilder Gagnon Howe & Co reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 252,219 Tobira Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $15.4M.
  • Gilder Gagnon Howe & Co first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 2 quarters.
  • Gilder Gagnon Howe & Co's Tobira Therapeutics, Inc. Common Stock position peaked at $15.4M in Q2 2014.
  • 47 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2014.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2014, filed 13 Nov 2014.